Two vaccine candidates using similar technology are winning the COVID-19 vaccine race in the U.S., and in the process validating the mRNA platform — which is yet untested on the market — as well as ...

Under the deal, Moderna will pay US$950 million (S$1.21 billion) upfront in July 2026. Read more at straitstimes.com. Read more at straitstimes.com.

Moderna will pay US$950-million upfront in July, 2026, with an additional US$1.3-billion contingent on the outcome of a separate legal appeal, while not owing royalties for the technology in its ...

Arbutus and Genevant's complaint claimed that Moderna's mRNA-based Spikevax shot used lipid nanoparticle (LNP) delivery ...

This ends a drawn out legal battle brought by Genevant and Arbutus against Moderna under a week before the jury trial was set to begin.

WASHINGTON — Pfizer and Moderna say the Food and Drug Administration have opened up COVID-19 booster shots to all adults, letting them choose another dose of either vaccine. The move expands the ...

A recent study suggests people may have protection from the coronavirus for years if they received the Pfizer-BioNTech or Moderna vaccine. The study was published in the journal Nature. “Overall, our ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A box of Moderna Spikevax (COVID-19 Vaccine, mRNA) is kept in the refrigerator at Skippack Pharmacy in Schwenksville, ...

Now that Pfizer’s COVID-19 vaccine has gotten full FDA approval, how close is Moderna’s vaccine to the same sign-off? Here's what we know so far. The Food and Drug Administration on Monday granted ...

Moderna shares rose ​9% on Wednesday after it settled a long-running legal ​battle over the technology that made its COVID-19 vaccine possible, removing an overhang and allowing it to focus on its ...

SAN FRANCISCO -- Herculean efforts by scientists and physicians around the world have resulted more than 50 experimental COVID-19 vaccines currently in global clinical trials. The focus in the U.S.